TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.
- DOI
- 10.1186/s12885-017-3360-z
- Published
- 2017 Jun 9
- Container
- BMC cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-017-3360-z,
title = {TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.},
author = {Cremolini C and Marmorino F and Loupakis F and Masi G and Antoniotti C and Salvatore L and Schirripa M and Boni L and Zagonel V and Lonardi S and Aprile G and Tamburini E and Ricci V and Ronzoni M and Pietrantonio F and Valsuani C and Tomasello G and Passardi A and Allegrini G and Di Donato S and Santini D and Falcone A and all the investigators of the Gruppo Oncologico del Nord Ovest},
year = {2017},
journal = {BMC cancer},
doi = {10.1186/s12885-017-3360-z},
url = {https://doi.org/10.1186/s12885-017-3360-z}
}RIS
TY - JOUR TI - TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group. AU - Cremolini C AU - Marmorino F AU - Loupakis F AU - Masi G AU - Antoniotti C AU - Salvatore L AU - Schirripa M AU - Boni L AU - Zagonel V AU - Lonardi S AU - Aprile G AU - Tamburini E AU - Ricci V AU - Ronzoni M AU - Pietrantonio F AU - Valsuani C AU - Tomasello G AU - Passardi A AU - Allegrini G AU - Di Donato S AU - Santini D AU - Falcone A AU - all the investigators of the Gruppo Oncologico del Nord Ovest PY - 2017 JO - BMC cancer DO - 10.1186/s12885-017-3360-z UR - https://doi.org/10.1186/s12885-017-3360-z ER -
APA
C, C., F, M., F, L., G, M., C, A., L, S., M, S., L, B., V, Z., S, L., G, A., E, T., V, R., M, R., F, P., C, V., G, T., A, P., G, A., S, D. D., D, S., A, F., & Ovest, A. T. I. O. T. G. O. D. N. (2017). TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.. BMC cancer. https://doi.org/10.1186/s12885-017-3360-z
Source records
- pubmed · retrieved 2026-09-27T01:37:25.295Z